Dompé agrees to pay $32 million over Medicare co-pay allegations
Dompé will pay $32 million plus interest to resolve DOJ allegations involving foundation-funded Medicare co-pays for its Oxervate eye treatment.
Dompé will pay $32 million plus interest to resolve DOJ allegations involving foundation-funded Medicare co-pays for its Oxervate eye treatment.
A six-month federal health-care enforcement report cited $5.56 billion in expected recoveries and projected savings, 1,212 exclusions and major Medicare Advantage settlements.